Literature DB >> 24629670

Differential metal content and gene expression in rat left ventricular hypertrophy due to hypertension and hyperactivity.

Meenakumari Subramanian1, Adam L Hunt2, Giuseppe A Petrucci2, Zengyi Chen3, Edith D Hendley1, Bradley M Palmer4.   

Abstract

The spontaneously hypertensive rat (SHR) has been studied extensively as a model of left ventricular hypertrophy (LVH) and associated cardiac dysfunction due to hypertension (HT). The SHR also possesses a hyperactive trait (HA). Crossbreeding SHR with Wistar-Kyoto (WKY) control rats, which are nonHT and nonHA, followed by selected inbreeding produced two additional homozygous strains: WKHT and WKHA, in which the traits of HT and HA, respectively, are expressed separately. WKHT, WKHA and SHR all display LVH, but only the SHR exhibits cardiac dysfunction. We hypothesized that cardiac dysfunction in the SHR is uniquely characterized by calcium overload. We measured total cardiac Ca, Cu, Fe, K, Mg and Zn in the four strains. We found elevated Ca and depressed Cu, Mg and Zn with HT, but not unique to SHR. We surmise that HT promotes aberrant regulation of cardiac Ca(2+), Cu(2+), Mg(2+) and Zn(2+), which does not necessarily result in cardiac dysfunction. Interestingly, Cu was elevated in HA strains compared to nonHA counterparts. We then analyzed gene expression as mRNA of Cu-containing proteins, most notably mitochondrial-Cox, Dbh, Lox, Loxl1, Loxl2, Sod1 and Tyr. The gene expression profiles of Lox, Loxl1, Loxl2 and Sod1 were found especially high in the WKHA, which if reflective of protein content could account for the high Cu content in the WKHA. The mRNA of other genes, notably Mb, Fxyd1, Maoa and Maob were also examined. We found that Maoa gene expression and monoamine oxidase-A (MAO-A) protein content were low in the SHR compared to the other strains. The finding that MAO-A protein is low in the SHR and normal in the WKHT and WKHA strains is most consistent with the idea that MAO-A protects against the development of cardiac dysfunction in LVH but not against LVH in these rats.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Calcium; Cardiac hypertrophy; Copper; Monoamine oxidase; Zinc

Mesh:

Substances:

Year:  2014        PMID: 24629670      PMCID: PMC4082731          DOI: 10.1016/j.jtemb.2014.02.002

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  30 in total

1.  Cardiomyocyte function associated with hyperactivity and/or hypertension in genetic models of LV hypertrophy.

Authors:  Bradley M Palmer; Zengyi Chen; Richard R Lachapelle; Edith D Hendley; Martin M LeWinter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-21       Impact factor: 4.733

2.  Low power, type II errors, and other statistical problems in recent cardiovascular research.

Authors:  J L Williams; C A Hathaway; K L Kloster; B H Layne
Journal:  Am J Physiol       Date:  1997-07

3.  A new hypertrophic mechanism of serotonin in cardiac myocytes: receptor-independent ROS generation.

Authors:  Pascale Bianchi; David R Pimentel; Michael P Murphy; Wilson S Colucci; Angelo Parini
Journal:  FASEB J       Date:  2005-02-09       Impact factor: 5.191

4.  A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study.

Authors:  G J S Cooper; A A Young; G D Gamble; C J Occleshaw; A M Dissanayake; B R Cowan; D H Brunton; J R Baker; A R J Phillips; C M Frampton; S D Poppitt; R N Doughty
Journal:  Diabetologia       Date:  2009-01-27       Impact factor: 10.122

5.  Hypertrophy of stellate ganglion cells in hypertensive, but not hyperactive, rats.

Authors:  D Peruzzi; E D Hendley; C J Forehand
Journal:  Am J Physiol       Date:  1991-10

6.  Extracellular superoxide dismutase regulates cardiac function and fibrosis.

Authors:  Corrine R Kliment; Hagir B Suliman; Jacob M Tobolewski; Crystal M Reynolds; Brian J Day; Xiaodong Zhu; Charles F McTiernan; Kenneth R McGaffin; Claude A Piantadosi; Tim D Oury
Journal:  J Mol Cell Cardiol       Date:  2009-08-18       Impact factor: 5.000

7.  Regional differences in brain norepinephrine and dopamine uptake kinetics in inbred rat strains with hypertension and/or hyperactivity.

Authors:  E D Hendley; X M Fan
Journal:  Brain Res       Date:  1992-07-17       Impact factor: 3.252

8.  Inbreeding of Wistar-Kyoto rat strain with hyperactivity but without hypertension.

Authors:  E D Hendley; D J Wessel; J Van Houten
Journal:  Behav Neural Biol       Date:  1986-01

9.  Differential development of vascular and cardiac hypertrophy in genetic hypertension. Relation to sympathetic function.

Authors:  M A Adams; A Bobik; P I Korner
Journal:  Hypertension       Date:  1989-08       Impact factor: 10.190

10.  Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload.

Authors:  Olivier Lairez; Denis Calise; Pascale Bianchi; Catherine Ordener; Odile Spreux-Varoquaux; Céline Guilbeau-Frugier; Ghislaine Escourrou; Isabelle Seif; Jérôme Roncalli; Nathalie Pizzinat; Michel Galinier; Angelo Parini; Jeanne Mialet-Perez
Journal:  J Mol Cell Cardiol       Date:  2009-01-07       Impact factor: 5.000

View more
  2 in total

1.  Relaxation and the Role of Calcium in Isolated Contracting Myocardium From Patients With Hypertensive Heart Disease and Heart Failure With Preserved Ejection Fraction.

Authors:  K Elisabeth Runte; Stephen P Bell; Donald E Selby; Tim N Häußler; Takamuru Ashikaga; Martin M LeWinter; Bradley M Palmer; Markus Meyer
Journal:  Circ Heart Fail       Date:  2017-08       Impact factor: 8.790

2.  LOXL2 silencing suppresses angiotensin II-induced cardiac hypertrophy through the EMT process and TGF-β1/Smad3/NF-κB pathway.

Authors:  Jun Luo; Yingbiao Wu; Xi Zhu; Saihua Wang; Xiaogang Zhang; Zhongping Ning
Journal:  Iran J Basic Med Sci       Date:  2022-08       Impact factor: 2.532

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.